Reuters -- Swiss drugmaker Roche Holding AG (ROG.VX) is seeking to broaden its use of cancer drug Rituxan in non-Hodgkin’s lymphoma in the United States, coming hot on the heels of its bid to expand use of the drug in Europe.
Reuters -- Swiss drugmaker Roche Holding AG (ROG.VX) is seeking to broaden its use of cancer drug Rituxan in non-Hodgkin’s lymphoma in the United States, coming hot on the heels of its bid to expand use of the drug in Europe.
